• Capricor Therapeutics (NASDAQ:CAPR) Lifted to “Strong-Buy” at Zacks Investment Research

    Zacks Investment Research upgraded shares of Capricor Therapeutics (NASDAQ:CAPR) from a hold rating to a strong-buy rating in a research note …

    Read More
  • 0 0